The role of chemokine receptors in acute lung allograft rejection

European Respiratory Journal

Volumn 35, Issue 1, 2010, Pages 167-175

  Geleff, S ^a   Draganovici, D ^b   Jaksch, P ^a   Segerer, S ^c,d  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Chemokine receptors; CXCR1; CXCR3; Duffy antigen receptor for chemokines; Lung allograft rejection

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR3; CYCLOSPORIN; DUFFY ANTIGEN RECEPTOR FOR CHEMOKINE; DUFFY BINDING PROTEIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; UNCLASSIFIED DRUG;

ACUTE GRAFT REJECTION; ADOLESCENT; ADULT; AGED; ARTICLE; BRONCHIOLE; BRONCHIOLITIS OBLITERANS; BRONCHUS; CAPILLARY; CELL INFILTRATION; CELL TYPE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LEUKOCYTE; LUNG BIOPSY; LUNG GRAFT REJECTION; LUNG HEMOSIDEROSIS; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; T LYMPHOCYTE;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; DUFFY BLOOD-GROUP SYSTEM; FEMALE; GRAFT REJECTION; HUMANS; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; RECEPTORS, CCR5; RECEPTORS, CELL SURFACE; RECEPTORS, CXCR3; RECEPTORS, INTERLEUKIN-8A; YOUNG ADULT;

EID: 75149120334     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00042309     Document Type: Article

References (33)

1. Lynch JP 3rd, Saggar R, Weigt SS, et al. Overview of lung transplantation and criteria for selection of candidates. Semin Respir Crit Care Med 2006; 27: 441-469.
2. Snyder LD, Palmer SM. Immune mechanisms of lung allograft rejection. Semin Respir Crit Care Med 2006; 27: 534-543.
3. Murphy PM, Baggiolini M, Charo IF, et al. International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol Rev 2000; 52: 145-176.
4. Hancock WW. Chemokines and transplant immunobiology. J Am Soc Nephrol 2002; 13: 821-824.
5. Colvin BL, Thomson AW. Chemokines, their receptors, and transplant outcome. Transplantation 2002; 74: 149-155.
6. De Perrot M, Sekine Y, Fischer S, et al. Interleukin-8 release during early reperfusion predicts graft function in human lung transplantation. Am J Respir Crit Care Med 2002; 165: 211-215.
7. Belperio JA, Keane MP, Burdick MD, et al. CXCR2/CXCR2 ligand biology during lung transplant ischemia-reperfusion injury. J Immunol 2005; 175: 6931-6939.
8. Belperio JA, Keane MP, Burdick MD, et al. Role of CXCL9/CXCR3 chemokine biology during pathogenesis of acute lung allograft rejection. J Immunol 2003; 171: 4844-4852.
9. Sekine Y, Yasufuku K, Heidler KM, et al. Monocyte chemoattractant protein-1 and RANTES are chemotactic for graft infiltrating lymphocytes during acute lung allograft rejection. Am J Respir Cell Mol Biol 2000; 23: 719-726.
10. Belperio JA, Burdick MD, Keane MP, et al. The role of the CC chemokine, RANTES, in acute lung allograft rejection. J Immunol 2000; 165: 461-472.
11. Nibbs R, Graham G, Rot A. Chemokines on the move: control by the chemokine "interceptors" Duffy blood group antigen and D6. Semin Immunol 2003; 15: 287-294.
12. Pruenster M, Mudde L, Bombosi P, et al. The Duffy antigen receptor for chemokines transports chemokines and supports their promigratory activity. Nat Immunol 2009; 10: 101-108.
13. Hadley TJ, Peiper SC. From malaria to chemokine receptor: the emerging physiologic role of the Duffy blood group antigen. Blood 1997; 89: 3077-3091.
14. Rot A, von Andrian UH. Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu Rev Immunol 2004; 22: 891-928.
15. Lee JS, Frevert CW, Thorning DR, et al. Enhanced expression of Duffy antigen in the lungs during suppurative pneumonia. J Histochem Cytochem 2003; 51: 159-166.
16. Stewart S, Fishbein MC, Snell GI, et al. Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection. J Heart Lung Transplant 2007; 26: 1229-1242.
17. Bruhl H, Vielhauer V, Weiss M, et al. Expression of DARC, CXCR3 and CCR5 in giant cell arteritis. Rheumatology (Oxford) 2005; 44: 309-313.
18. Gardner L, Patterson AM, Ashton BA, et al. The human Duffy antigen binds selected inflammatory but not homeostatic chemokines. Biochem Biophys Res Commun 2004; 321: 306-312.
19. Horuk R, Wang ZX, Peiper SC, et al. Identification and characterization of a promiscuous chemokine-binding protein in a human erythroleukemic cell line. J Biol Chem 1994; 269: 17730-17733.
20. Middleton J, Patterson AM, Gardner L, et al. Leukocyte extravasation: chemokine transport and presentation by the endothelium. Blood 2002; 100: 3853-3860.
21. Cartron JP, Bailly P, Le Van Kim C, et al. Insights into the structure and function of membrane polypeptides carrying blood group antigens. Vox Sang 1998; 74: Suppl. 2, 29-64.
22. Darbonne WC, Rice GC, Mohler MA, et al. Red blood cells are a sink for interleukin 8, a leukocyte chemotaxin. J Clin Invest 1991; 88: 1362-1369.
23. Girard JP, Baekkevold ES, Yamanaka T, et al. Heterogeneity of endothelial cells: the specialized phenotype of human high endothelial venules characterized by suppression subtractive hybridization. Am J Pathol 1999; 155: 2043-2055.
24. Segerer S, Regele H, Mac KM, et al. The Duffy antigen receptor for chemokines is up-regulated during acute renal transplant rejection and crescentic glomerulonephritis. Kidney Int 2000; 58: 1546-1556.
25. Segerer S, Bohmig GA, Exner M, et al. When renal allografts turn DARC. Transplantation 2003; 75: 1030-1034.
26. Monti G, Magnan A, Fattal M, et al. Intrapulmonary production of RANTES during rejection and CMV pneumonitis after lung transplantation. Transplantation 1996; 61: 1757-1762.
27. Reynaud-Gaubert M, Marin V, Thirion X, et al. Upregulation of chemokines in bronchoalveolar lavage fluid as a predictive marker of post-transplant airway obliteration. J Heart Lung Transplant 2002; 21: 721-730.
28. Weigt SS, Elashoff RM, Keane MP, et al. Altered levels of CC chemokines during pulmonary CMV predict BOS and mortality post-lung transplantation. Am J Transplant 2008; 8: 1512-1522.
29. Agostini C, Calabrese F, Rea F, et al. CXCR3 and its ligand CXCL10 are expressed by inflammatory cells infiltrating lung allografts and mediate chemotaxis of T cells at sites of rejection. Am J Pathol 2001; 158: 1703-1711.
30. Meyer KC, Nunley DR, Dauber JH, et al. Neutrophils, unopposed neutrophil elastase, and α1-antiprotease defenses following human lung transplantation. Am J Respir Crit Care Med 2001; 164: 97-102.
31. Buonocore S, Surquin M, Le Moine A, et al. Amplification of T-cell responses by neutrophils: relevance to allograft immunity. Immunol Lett 2004; 94: 163-166.
32. Elssner A, Vogelmeier C. The role of neutrophils in the pathogenesis of obliterative bronchiolitis after lung transplantation. Transpl Infect Dis 2001; 3: 168-176.
33. Bharat A, Narayanan K, Street T, et al. Early posttransplant inflammation promotes the development of alloimmunity and chronic human lung allograft rejection. Transplantation 2007; 83: 150-158.